NO20034930L - Substituerte cykloheksan-1,4-diaminderivater - Google Patents

Substituerte cykloheksan-1,4-diaminderivater

Info

Publication number: NO20034930L
Authority: NO; Norway
Prior art keywords: substituted cyclohexane; diamine derivatives; diamine; cyclohexane; derivatives
Prior art date: 2001-05-09

Application number

NO20034930A

Other languages

English (en)

Other versions

NO20034930D0 (no

NO328600B1 (no

Inventor

Bernd Sundermann

Hagen-Heinrich Hennies

Werner Guenter Englberger

Babette-Yvonne Koegel

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-09

Filing date

2003-11-05

Publication date

2004-01-05

2003-11-05 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2003-11-05 Publication of NO20034930D0 publication Critical patent/NO20034930D0/no

2004-01-05 Publication of NO20034930L publication Critical patent/NO20034930L/no

2010-03-29 Publication of NO328600B1 publication Critical patent/NO328600B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/36—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing at least two amino groups bound to the carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Gynecology & Obstetrics (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Obesity (AREA)
Anesthesiology (AREA)
Child & Adolescent Psychology (AREA)

NO20034930A 2001-05-09 2003-11-05 Substituerte sykloheksan-1,4-diaminderivater, anvendelse derav, fremgangsmate for fremstilling derav og legemidler inneholdende slike derivater NO328600B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10123163A DE10123163A1 (de)	2001-05-09	2001-05-09	Substituierte Cyclohexan-1,4-diaminderivate
PCT/EP2002/005051 WO2002090317A1 (de)	2001-05-09	2002-05-08	Substituierte cyclohexan-1,4-diaminderivate

Publications (3)

Publication Number	Publication Date
NO20034930D0 NO20034930D0 (no)	2003-11-05
NO20034930L true NO20034930L (no)	2004-01-05
NO328600B1 NO328600B1 (no)	2010-03-29

Family

ID=7684562

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20034930A NO328600B1 (no)	2001-05-09	2003-11-05	Substituerte sykloheksan-1,4-diaminderivater, anvendelse derav, fremgangsmate for fremstilling derav og legemidler inneholdende slike derivater
NO20034931A NO326784B1 (no)	2001-05-09	2003-11-05	Substituerte 2-pyridin-cykloheksan-1,4-diaminderivater, fremgangsmåte for deres fremstilling, anvendelser samt legemiddel

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20034931A NO326784B1 (no)	2001-05-09	2003-11-05	Substituerte 2-pyridin-cykloheksan-1,4-diaminderivater, fremgangsmåte for deres fremstilling, anvendelser samt legemiddel

Country Status (30)

Country	Link
US (3)	US6998409B2 (no)
EP (3)	EP1392641B1 (no)
JP (3)	JP2004528374A (no)
KR (2)	KR20040002943A (no)
CN (2)	CN1307158C (no)
AR (1)	AR035883A1 (no)
AT (2)	ATE370120T1 (no)
AU (3)	AU2002341195B2 (no)
BR (2)	BR0209580A (no)
CA (3)	CA2446461C (no)
CO (2)	CO5540300A2 (no)
CY (2)	CY1106468T1 (no)
CZ (2)	CZ20032995A3 (no)
DE (3)	DE10123163A1 (no)
DK (2)	DK1392641T3 (no)
EC (2)	ECSP034830A (no)
ES (2)	ES2291486T3 (no)
HU (3)	HU228253B1 (no)
IL (4)	IL158784A0 (no)
MX (3)	MXPA03010201A (no)
NO (2)	NO328600B1 (no)
NZ (2)	NZ529334A (no)
PE (1)	PE20021094A1 (no)
PL (3)	PL212887B1 (no)
PT (2)	PT1385825E (no)
RU (2)	RU2321579C2 (no)
SI (2)	SI1392641T1 (no)
SK (2)	SK287319B6 (no)
WO (3)	WO2002090317A1 (no)
ZA (2)	ZA200309522B (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10252650A1 (de) *	2002-11-11	2004-05-27	Grünenthal GmbH	Cyclohexyl-Harnstoff-Derivate
DE10252665A1 (de)	2002-11-11	2004-06-03	Grünenthal GmbH	4-Aminomethyl-1-aryl-cyclohexylamin-Derivate
AU2003296564A1 (en)	2002-11-12	2004-06-03	Grunenthal Gmbh	4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
MXPA05005379A (es)	2002-11-19	2006-02-17	Achillion Pharmaceuticals Inc	Tioureas de arilo sustituidas y compuestos relacionados; inhibidores de duplicacion viral.
US7026432B2 (en)	2003-08-12	2006-04-11	General Electric Company	Electrically conductive compositions and method of manufacture thereof
US7354988B2 (en)	2003-08-12	2008-04-08	General Electric Company	Electrically conductive compositions and method of manufacture thereof
US7378409B2 (en)	2003-08-21	2008-05-27	Bristol-Myers Squibb Company	Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
US7309727B2 (en)	2003-09-29	2007-12-18	General Electric Company	Conductive thermoplastic compositions, methods of manufacture and articles derived from such compositions
DE10360792A1 (de) *	2003-12-23	2005-07-28	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE10360793A1 (de) *	2003-12-23	2005-07-28	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE102004023501A1 (de) *	2004-05-10	2005-12-01	Grünenthal GmbH	Oxosubstituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023522A1 (de) *	2004-05-10	2005-12-01	Grünenthal GmbH	Substituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023632A1 (de)	2004-05-10	2005-12-08	Grünenthal GmbH	Substituierte Cyclohexylcarbonsäure-Derivate
DE102004023635A1 (de)	2004-05-10	2006-04-13	Grünenthal GmbH	Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate
DE102004023508A1 (de)	2004-05-10	2005-12-08	Grünenthal GmbH	Säurederivate substituierter Cyclohexyl-1,4-diamine
DE102004023507A1 (de)	2004-05-10	2005-12-01	Grünenthal GmbH	Substituierte Cyclohexylessigsäure-Derivate
DE102004023506A1 (de)	2004-05-10	2005-12-01	Grünenthal GmbH	Kettenverlängerte substituierte Cyclohexyl-1,4-diamin-Derivate
TW200600492A (en) *	2004-05-18	2006-01-01	Achillion Pharmaceuticals Inc	Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
US7462656B2 (en)	2005-02-15	2008-12-09	Sabic Innovative Plastics Ip B.V.	Electrically conductive compositions and method of manufacture thereof
DE102005061428A1 (de)	2005-12-22	2007-08-16	Grünenthal GmbH	Substituierte Cyclohexylmethyl-Derivate
DE102006033109A1 (de) *	2006-07-18	2008-01-31	Grünenthal GmbH	Substituierte Heteroaryl-Derivate
DE102006033114A1 (de)	2006-07-18	2008-01-24	Grünenthal GmbH	Spirocyclische Azaindol-Derivate
DE102006035787A1 (de)	2006-07-28	2008-03-13	Tesa Ag	Verfahren zum Stanzen von bei Raumtemperatur nicht tackigen hitzeaktivierbaren Klebmassen
WO2008089307A2 (en) *	2007-01-18	2008-07-24	Lexicon Pharmaceuticals, Inc.	Delta 5 desaturase inhibitors for the treatment of pain, inflammation and cancer
EP2166841A4 (en) *	2007-06-15	2014-05-07	Mission Pharma Co	METHOD AND COMPOSITION FOR INHIBITING THE EDEMA FACTOR AND THE ADENYLYL CYCLASE
US20090215725A1 (en) *	2008-02-26	2009-08-27	Grunenthal Gmbh	Substituted 4-aminocyclohexane derivatives
CA2719743A1 (en) *	2008-03-27	2009-10-01	Gruenenthal Gmbh	Substituted cyclohexyldiamines
RU2532545C2 (ru) *	2008-03-27	2014-11-10	Грюненталь Гмбх	Замещенные производные 4-аминоциклогексана
US8288430B2 (en)	2008-03-27	2012-10-16	Grunenthal Gmbh	Spiro(5.5)undecane derivatives
SI2271613T1 (sl)	2008-03-27	2014-08-29	Grunenthal Gmbh	Hidroksimetilcikloheksilamini
TWI450899B (zh)	2008-03-27	2014-09-01		被取代之螺環環已烷衍生物
AR071066A1 (es)	2008-03-27	2010-05-26	Gruenenthal Chemie	Derivados de (hetero) aril-ciclohexano
BRPI0911031B8 (pt)	2008-07-21	2021-05-25	Purdue Pharma Lp	compostos de piperidina ligada do tipo quinoxalina substituídos e os usos destes
EP2389362B1 (en)	2009-01-21	2019-12-11	Oryzon Genomics, S.A.	Phenylcyclopropylamine derivatives and their medical use
KR101736218B1 (ko)	2009-09-25	2017-05-16	오리존 지노믹스 에스.에이.	라이신 특이적 디메틸라아제-1 억제제 및 이의 용도
US8946296B2 (en)	2009-10-09	2015-02-03	Oryzon Genomics S.A.	Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
WO2011106573A2 (en)	2010-02-24	2011-09-01	Oryzon Genomics, S.A.	Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
WO2011106574A2 (en)	2010-02-24	2011-09-01	Oryzon Genomics, S.A.	Inhibitors for antiviral use
BR122019020471B1 (pt)	2010-04-19	2021-06-22	Oryzon Genomics S.A.	Inibidores da desmetilase específica para lisina 1, seus usos e método para sua identificação, e composições farmacêuticas
WO2012013728A1 (en)	2010-07-29	2012-02-02	Oryzon Genomics S.A.	Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
US9006449B2 (en)	2010-07-29	2015-04-14	Oryzon Genomics, S.A.	Cyclopropylamine derivatives useful as LSD1 inhibitors
WO2012045883A1 (en)	2010-10-08	2012-04-12	Oryzon Genomics S.A.	Cyclopropylamine inhibitors of oxidases
WO2012072713A2 (en)	2010-11-30	2012-06-07	Oryzon Genomics, S.A.	Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
EP3981395A1 (en)	2011-02-08	2022-04-13	Oryzon Genomics, S.A.	Lysine demethylase inhibitors for myeloproliferative disorders
UA116765C2 (uk)	2011-10-20	2018-05-10	Орізон Джіномікс, С.А.	(гетеро)арилциклопропіламіни як інгібітори lsd1
CN104203914B (zh)	2011-10-20	2017-07-11	奥瑞泽恩基因组学股份有限公司	作为lsd1抑制剂的(杂)芳基环丙胺化合物
US12084472B2 (en)	2015-12-18	2024-09-10	Ardelyx, Inc.	Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
TWI773657B (zh)	2015-12-18	2022-08-11	美商亞德利克斯公司	作爲非全身ｔｇｒ５促效劑之經取代之4-苯基吡啶化合物

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU172460B (hu) *	1975-10-03	1978-09-28	Chinoin Gyogyszer Es Vegyeszet	Sposob poluchenija novykh proizvodnykh 5,6-digidro-3h-pirimidin-4-ona
US4065573A (en) *	1976-06-03	1977-12-27	The Upjohn Company	4-Amino-4-phenylcyclohexanone ketal compositions and process of use
US4113866A (en) *	1977-04-01	1978-09-12	The Upjohn Company	Analgetic compounds, compositions and process of treatment
US4447454A (en) *	1977-04-01	1984-05-08	The Upjohn Company	Analgetic compounds, compositions and process of treatment
US5877277A (en)	1987-09-24	1999-03-02	Biomeasure, Inc.	Octapeptide bombesin analogs
US4906655A (en)	1989-01-24	1990-03-06	Warner-Lambert Company	Novel 1,2-cyclohexylaminoaryl amides useful as analgesic agents
US5153226A (en)	1989-08-31	1992-10-06	Warner-Lambert Company	Acat inhibitors for treating hypocholesterolemia
EP0524439A1 (en) *	1991-07-24	1993-01-27	F.Hoffmann-La Roche & Co. Aktiengesellschaft	Novel cyclohexane and tetrahydropyran derivatives and antifungal compositions containing these derivatives
FR2687147A1 (fr)	1992-02-11	1993-08-13	Union Pharma Scient Appl	Nouveaux derives d'alpha-amino n-pyridyl benzene propanamide, leurs procedes de preparation, compositions pharmaceutiques les contenant.
US5620955A (en)	1993-06-18	1997-04-15	Peptide Technologies Corporation	Bombesin receptor antagonists and uses thereof
GB9411099D0 (en) *	1994-06-03	1994-07-27	Wyeth John & Brother Ltd	Piperazine derivatives
US5565568A (en)	1995-04-06	1996-10-15	Eli Lilly And Company	2-acylaminopropanamides as tachykinin receptor antagonists
EP0761220A1 (en)	1995-08-21	1997-03-12	Eli Lilly And Company	2-Acylaminopropanamides as growth hormone secretagogues
CA2255966A1 (en)	1996-08-22	1998-02-26	Warner-Lambert Company	Non-peptide bombesin receptor antagonists
JP3342478B2 (ja) *	1998-01-19	2002-11-11	ファイザー製薬株式会社	Ｏｒｌ１−レセプターアゴニストとしての４−（２−ケト−１−ベンズイミダゾリニル）ピペリジン化合物
US20020169101A1 (en)	1999-05-10	2002-11-14	Gonzalez Maria Isabel	Treatment of sexual dysfunction
GB0006289D0 (en)	2000-03-15	2000-05-03	Smithkline Beecham Plc	New use
GB0012240D0 (en) *	2000-05-19	2000-07-12	Merck Sharp & Dohme	Therapeutic agents
US20020028799A1 (en)	2000-07-06	2002-03-07	Naylor Alasdair Mark	Treatment of male sexual dysfunction
US6991916B2 (en)	2000-07-14	2006-01-31	Pfizer Inc.	Compounds for the treatment of sexual dysfunction
AU2001294196B2 (en) *	2000-10-06	2005-11-17	Tanabe Seiyaku Co., Ltd.	Nitrogenous five-membered ring compounds
US20020055759A1 (en)	2000-11-06	2002-05-09	Shibuya Terry Y.	Bioactive surgical suture
WO2002040468A1 (en)	2000-11-16	2002-05-23	Smithkline Beecham Corporation	Compounds
GB2369117A (en)	2000-11-17	2002-05-22	Warner Lambert Co	Bombesin receptor antagonists
PL362980A1 (en)	2000-11-17	2004-11-02	Warner-Lambert Company Llc	Treatment of sexual dysfunction
GB2369118A (en)	2000-11-17	2002-05-22	Warner Lambert Co	Bombesin receptor antagonists
IL155703A0 (en)	2000-11-17	2003-11-23	Warner Lambert Co	Treatment of sexual dysfunction with non peptide bombesin receptor antagonists
AU2001214046A1 (en)	2000-11-17	2002-05-27	Warner-Lambert Company Llc	Treatment of sexual dysfunction using bombesin antagonist
US20030119714A1 (en)	2000-12-15	2003-06-26	Naylor Alasdair Mark	Treatment of male sexual dysfunction

2001
- 2001-05-09 DE DE10123163A patent/DE10123163A1/de not_active Withdrawn
2002
- 2002-05-08 CN CNB028135571A patent/CN1307158C/zh not_active Expired - Fee Related
- 2002-05-08 JP JP2002587410A patent/JP2004528374A/ja active Pending
- 2002-05-08 EP EP02738038A patent/EP1392641B1/de not_active Expired - Lifetime
- 2002-05-08 EP EP02750900A patent/EP1385825B1/de not_active Expired - Lifetime
- 2002-05-08 NZ NZ529334A patent/NZ529334A/en not_active IP Right Cessation
- 2002-05-08 SI SI200230571T patent/SI1392641T1/sl unknown
- 2002-05-08 IL IL15878402A patent/IL158784A0/xx unknown
- 2002-05-08 PL PL368851A patent/PL212887B1/pl unknown
- 2002-05-08 SI SI200230627T patent/SI1385825T1/sl unknown
- 2002-05-08 DE DE50210707T patent/DE50210707D1/de not_active Expired - Lifetime
- 2002-05-08 MX MXPA03010201A patent/MXPA03010201A/es active IP Right Grant
- 2002-05-08 HU HU0400888A patent/HU228253B1/hu not_active IP Right Cessation
- 2002-05-08 DK DK02738038T patent/DK1392641T3/da active
- 2002-05-08 CZ CZ20032995A patent/CZ20032995A3/cs unknown
- 2002-05-08 WO PCT/EP2002/005051 patent/WO2002090317A1/de not_active Ceased
- 2002-05-08 DK DK02750900T patent/DK1385825T3/da active
- 2002-05-08 PT PT02750900T patent/PT1385825E/pt unknown
- 2002-05-08 CN CN028137531A patent/CN1533374B/zh not_active Expired - Fee Related
- 2002-05-08 BR BR0209580-7A patent/BR0209580A/pt not_active Application Discontinuation
- 2002-05-08 CA CA2446461A patent/CA2446461C/en not_active Expired - Fee Related
- 2002-05-08 SK SK1379-2003A patent/SK287319B6/sk not_active IP Right Cessation
- 2002-05-08 CA CA2446463A patent/CA2446463C/en not_active Expired - Fee Related
- 2002-05-08 HU HU0400989A patent/HU229288B1/hu not_active IP Right Cessation
- 2002-05-08 NZ NZ529147A patent/NZ529147A/en not_active IP Right Cessation
- 2002-05-08 IL IL15878202A patent/IL158782A0/xx unknown
- 2002-05-08 RU RU2003134147/04A patent/RU2321579C2/ru not_active IP Right Cessation
- 2002-05-08 AU AU2002341195A patent/AU2002341195B2/en not_active Ceased
- 2002-05-08 DE DE50209929T patent/DE50209929D1/de not_active Expired - Lifetime
- 2002-05-08 AT AT02750900T patent/ATE370120T1/de active
- 2002-05-08 AU AU2002312883A patent/AU2002312883B2/en not_active Ceased
- 2002-05-08 WO PCT/EP2002/005078 patent/WO2002090330A1/de not_active Ceased
- 2002-05-08 BR BR0209579-3A patent/BR0209579A/pt active Search and Examination
- 2002-05-08 ES ES02750900T patent/ES2291486T3/es not_active Expired - Lifetime
- 2002-05-08 AT AT02738038T patent/ATE359260T1/de active
- 2002-05-08 KR KR10-2003-7014530A patent/KR20040002943A/ko not_active Ceased
- 2002-05-08 MX MXPA03010134A patent/MXPA03010134A/es active IP Right Grant
- 2002-05-08 SK SK1378-2003A patent/SK286617B6/sk not_active IP Right Cessation
- 2002-05-08 KR KR1020037014568A patent/KR100895778B1/ko not_active Expired - Fee Related
- 2002-05-08 ES ES02738038T patent/ES2284876T3/es not_active Expired - Lifetime
- 2002-05-08 PL PL366662A patent/PL220595B1/pl unknown
- 2002-05-08 RU RU2003134145/04A patent/RU2287523C2/ru not_active IP Right Cessation
- 2002-05-08 PT PT02738038T patent/PT1392641E/pt unknown
- 2002-05-08 CZ CZ20033005A patent/CZ20033005A3/cs unknown
- 2002-05-08 JP JP2002587399A patent/JP2004533439A/ja active Pending
- 2002-05-09 EP EP02769145A patent/EP1385493A1/de not_active Withdrawn
- 2002-05-09 MX MXPA03010195A patent/MXPA03010195A/es unknown
- 2002-05-09 PL PL02366631A patent/PL366631A1/xx not_active Application Discontinuation
- 2002-05-09 PE PE2002000388A patent/PE20021094A1/es not_active Application Discontinuation
- 2002-05-09 HU HU0400963A patent/HUP0400963A2/hu unknown
- 2002-05-09 CA CA002446735A patent/CA2446735A1/en not_active Abandoned
- 2002-05-09 WO PCT/EP2002/005122 patent/WO2002089783A1/de not_active Ceased
- 2002-05-09 JP JP2002586920A patent/JP2005515959A/ja not_active Withdrawn
- 2002-05-10 AR ARP020101704A patent/AR035883A1/es unknown
2003
- 2003-11-05 NO NO20034930A patent/NO328600B1/no not_active IP Right Cessation
- 2003-11-05 NO NO20034931A patent/NO326784B1/no not_active IP Right Cessation
- 2003-11-06 IL IL158784A patent/IL158784A/en not_active IP Right Cessation
- 2003-11-06 IL IL158782A patent/IL158782A/en not_active IP Right Cessation
- 2003-11-07 EC EC2003004830A patent/ECSP034830A/es unknown
- 2003-11-07 CO CO03098846A patent/CO5540300A2/es active IP Right Grant
- 2003-11-07 EC EC2003004831A patent/ECSP034831A/es unknown
- 2003-11-07 CO CO03098857A patent/CO5700725A2/es not_active Application Discontinuation
- 2003-11-10 US US10/704,200 patent/US6998409B2/en not_active Expired - Fee Related
- 2003-11-10 US US10/704,329 patent/US7276518B2/en not_active Expired - Fee Related
- 2003-11-10 US US10/704,524 patent/US20040229872A1/en not_active Abandoned
- 2003-12-08 ZA ZA2003/09522A patent/ZA200309522B/en unknown
- 2003-12-08 ZA ZA200309521A patent/ZA200309521B/xx unknown
2007
- 2007-05-07 AU AU2007202033A patent/AU2007202033B8/en not_active Ceased
- 2007-05-10 CY CY20071100630T patent/CY1106468T1/el unknown
- 2007-10-25 CY CY20071101374T patent/CY1108067T1/el unknown

Also Published As

Publication number	Publication date
CA2446461C (en)	2011-04-26
CN1533374B (zh)	2013-08-21
CN1533374A (zh)	2004-09-29
AU2007202033B8 (en)	2010-03-04
CZ20033005A3 (en)	2004-03-17
PL368851A1 (en)	2005-04-04
RU2287523C2 (ru)	2006-11-20
BR0209579A (pt)	2004-06-22
RU2003134147A (ru)	2005-05-20
NO20034931L (no)	2004-01-02
ECSP034830A (es)	2004-03-23
US20040229872A1 (en)	2004-11-18
HU228253B1 (en)	2013-02-28
DE50209929D1 (de)	2007-05-24
AU2007202033B2 (en)	2010-02-04
RU2321579C2 (ru)	2008-04-10
NZ529334A (en)	2004-10-29
BR0209580A (pt)	2004-06-22
HUP0400888A3 (en)	2008-03-28
CO5540300A2 (es)	2005-07-29
SI1385825T1 (sl)	2008-02-29
SK286617B6 (sk)	2009-02-05
HUP0400888A2 (hu)	2004-07-28
EP1385493A1 (de)	2004-02-04
MXPA03010195A (es)	2004-03-10
HUP0400963A2 (hu)	2004-08-30
IL158782A (en)	2010-04-15
ATE359260T1 (de)	2007-05-15
HU229288B1 (en)	2013-10-28
CA2446463A1 (en)	2002-11-14
NO20034930D0 (no)	2003-11-05
PT1385825E (pt)	2007-09-04
NZ529147A (en)	2006-10-27
IL158784A0 (en)	2004-05-12
CY1106468T1 (el)	2012-01-25
CY1108067T1 (el)	2014-02-12
AR035883A1 (es)	2004-07-21
ZA200309521B (en)	2004-09-28
MXPA03010201A (es)	2006-02-09
PL220595B1 (pl)	2015-11-30
CN1307158C (zh)	2007-03-28
DE50210707D1 (de)	2007-09-27
PT1392641E (pt)	2007-05-31
DK1385825T3 (da)	2007-11-05
ES2291486T3 (es)	2008-03-01
KR20040002943A (ko)	2004-01-07
CA2446463C (en)	2010-07-13
AU2007202033A1 (en)	2007-05-24
RU2003134145A (ru)	2005-05-20
HUP0400989A3 (en)	2011-08-29
CO5700725A2 (es)	2006-11-30
SK13782003A3 (sk)	2004-04-06
SK287319B6 (sk)	2010-07-07
WO2002089783A1 (de)	2002-11-14
AU2002312883B2 (en)	2007-09-06
CN1537100A (zh)	2004-10-13
PE20021094A1 (es)	2003-01-25
US7276518B2 (en)	2007-10-02
JP2004533439A (ja)	2004-11-04
NO326784B1 (no)	2009-02-16
US20040162287A1 (en)	2004-08-19
CZ20032995A3 (cs)	2004-02-18
CA2446735A1 (en)	2002-11-14
SI1392641T1 (sl)	2007-10-31
EP1392641B1 (de)	2007-04-11
ECSP034831A (es)	2004-03-23
NO20034931D0 (no)	2003-11-05
PL212887B1 (pl)	2012-12-31
AU2002341195B2 (en)	2007-01-04
CA2446461A1 (en)	2002-11-14
US6998409B2 (en)	2006-02-14
EP1392641A1 (de)	2004-03-03
MXPA03010134A (es)	2004-03-10
NO328600B1 (no)	2010-03-29
PL366662A1 (en)	2005-02-07
HK1062911A1 (en)	2004-12-03
ATE370120T1 (de)	2007-09-15
WO2002090317A1 (de)	2002-11-14
JP2005515959A (ja)	2005-06-02
DE10123163A1 (de)	2003-01-16
IL158784A (en)	2009-09-01
PL366631A1 (en)	2005-02-07
SK13792003A3 (sk)	2004-06-08
ES2284876T3 (es)	2007-11-16
DK1392641T3 (da)	2007-07-16
WO2002090330A1 (de)	2002-11-14
KR100895778B1 (ko)	2009-05-08
KR20040017214A (ko)	2004-02-26
EP1385825B1 (de)	2007-08-15
HUP0400989A2 (hu)	2004-08-30
EP1385825A1 (de)	2004-02-04
ZA200309522B (en)	2005-02-23
IL158782A0 (en)	2004-05-12
US20040147741A1 (en)	2004-07-29
JP2004528374A (ja)	2004-09-16
HK1070049A1 (en)	2005-06-10

Publication	Publication Date	Title
NO20034930D0 (no)	2003-11-05	Substituerte cykloheksan-1,4-diaminderivater
DE60225563D1 (de)	2008-04-24	4-amino-6-phenyl-pyrroloä2,3-düpyrimidin derivate
ATE319451T1 (de)	2006-03-15	Tetrahydrochinolin-derivate
NO20035634L (no)	2004-02-18	Diamin-derivater
HUS1500055I1 (hu)	2016-03-29	HIV-gátló pirimidinszármazékok
AU2002312883A1 (en)	2003-05-01	Substituted cyclohexane-1,4-diamine derivatives
ATE312827T1 (de)	2005-12-15	3-substituierte-4-pyrimidonderivate
DE60216115D1 (de)	2006-12-28	BENZIMIDAZO 4,5-föISOCHINOLINON-DERIVATE
DE602004024770D1 (de)	2010-02-04	Substituierte 8-perfluoro-6,7,8,9-tetrahydropyrimido-(1,2a) pyrimidin-4-on derivate
DE60305332D1 (de)	2006-06-22	IMIDAZOi1,2-AöPYRIDINE
EE200300447A (et)	2003-12-15	Asendatud bensofuraan-2-karboksamiidide derivaadid
DE60223031D1 (de)	2007-11-29	Arylpiperazin gebundene tetrahydroindolonderivate
ATE382601T1 (de)	2008-01-15	Substituierte 4-aminocyclohexanolderivate
DE60215804D1 (de)	2006-12-14	4-aminopyrimidine derivate
DE60202381D1 (de)	2005-01-27	Paroxetin-n-formyl-derivate
NO20044405L (no)	2004-10-15	Neurotensinaktive 2,3-diaryl-pyrazolidin derivater
IS7022A (is)	2003-11-10	Nýjar indólafleiður
ATE348799T1 (de)	2007-01-15	Substituierte cyclohexanderivate
IS7131A (is)	2004-01-29	Nýjar 2,4-díamínóþíasól afleiður
IS7299A (is)	2004-06-03	3,4-díhýdró-1H-ísókínólóín-2-ýl-afleiður
ES1050453Y (es)	2002-07-16	Luminaria estanca perfeccionada.
ES1049516Y (es)	2002-08-01	Pupitre universitario perfeccionado.
ES1050299Y (es)	2002-07-01	Lampara perfeccionada.
ES1048710Y (es)	2002-02-01	Lampara escamoteable perfeccionada.
DE60224192D1 (de)	2008-01-31	Antihaemorrhagische, betain-enthaltende zusammenseuzungen

Legal Events

Date	Code	Title	Description
2016-12-27	MM1K	Lapsed by not paying the annual fees